Literature DB >> 8727949

Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats.

Y Noguchi1, K Nomura, T Yoshikawa, K Fukuzawa, T Makino, A Tsuburaya, A Matsumoto.   

Abstract

The role of insulin resistance in the tumor-induced decrease in tissue lipoprotein lipase (LPL) activity was studied in vivo and vitro in methylcholanthrene-induced sarcoma-bearing rats. Intraperitoneal (i.p.) injection of 2U of regular insulin resulted in high-adipose LPL activity in control rats (CTR) of 122.0 +/- 42.4 U/mg tissue, but it had little effect on tumor-bearing rats (TBR), which showed a value of only 9.6 +/- 5.5 U/mg tissue (P = 0.002). When adjusted for serum insulin concentrations, adipose LPL activity remained significantly different between the TBR and CTR at 0.19 +/- 0.17 and 0.78 +/- 0.29 U/mg tissue, respectively (P = 0.02). Following the in vitro incubation with either 1.44 g/l glucose of 1 x 10-8 U insulin of adipose tissue fragments obtained from the TBR and the CTR, measurable LPL activity was maintained in the tissue from the CTR for 2 h but not in that from the TBR. These results suggest that the decreased LPL activities seen in the tumor-bearing state may be mediated by insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727949     DOI: 10.1007/BF00311587

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  A stable, radioactive substrate emulsion for assay of lipoprotein lipase.

Authors:  P Nilsson-Ehle; M C Schotz
Journal:  J Lipid Res       Date:  1976-09       Impact factor: 5.922

2.  Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients.

Authors:  D Heber; R T Chlebowski; D E Ishibashi; J N Herrold; J B Block
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

3.  Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancer.

Authors:  D M Russell; M Shike; E B Marliss; A S Detsky; F A Shepherd; R Feld; W K Evans; K N Jeejeebhoy
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

4.  Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models.

Authors:  B A Sherry; J Gelin; Y Fong; M Marano; H Wei; A Cerami; S F Lowry; K G Lundholm; L L Moldawer
Journal:  FASEB J       Date:  1989-06       Impact factor: 5.191

5.  Tumor-induced alterations in hepatic malic enzyme and carnitine palmitoyltransferase activity.

Authors:  Y Noguchi; N A Vydelingum; M F Brennan
Journal:  J Surg Res       Date:  1993-10       Impact factor: 2.192

6.  The reversal of increased gluconeogenesis in the tumor-bearing rat by tumor removal and food intake.

Authors:  Y Noguchi; N A Vydelingum; M F Brennan
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

7.  Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines.

Authors:  L L Moldawer; C Andersson; J Gelin; K G Lundholm
Journal:  Am J Physiol       Date:  1988-03

Review 8.  A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.

Authors:  J A Tayek
Journal:  J Am Coll Nutr       Date:  1992-08       Impact factor: 3.169

9.  Peripheral tissue metabolism in cancer-bearing man.

Authors:  M E Burt; T T Aoki; C M Gorschboth; M F Brennan
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

10.  Total parenteral nutrition in a methylcholanthrene-induced rat sarcoma model.

Authors:  M B Popp; S D Morrison; M F Brennan
Journal:  Cancer Treat Rep       Date:  1981
View more
  1 in total

1.  Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.

Authors:  Adrien Daigeler; Daigeler Adrien; Ludger Klein-Hitpass; Klein-Hitpass Ludger; Ingo Stricker; Stricker Ingo; Oliver Müller; Müller Oliver; Cornelius Kuhnen; Kuhnen Cornelius; Ansgar Michael Chromik; Chromik Ansgar Michael; Lars Steinstraesser; Steinstraesser Lars; Ole Goertz; Goertz Ole; Hans-Ulrich Steinau; Steinau Hans-Ulrich; Marcus Lehnhardt; Lehnhardt Marcus
Journal:  Langenbecks Arch Surg       Date:  2009-01-22       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.